Microbiología y Parasitología
Departamento
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Sevilla (16)
2023
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
2021
-
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic
Journal of Global Antimicrobial Resistance, Vol. 25, pp. 5-7
-
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance
Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol. 115, Núm. 10, pp. 1122-1129
2020
-
A Contemporary Picture of Enterococcal Endocarditis
Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494
-
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 730-737
2019
-
Role of age and comorbidities in mortality of patients with infective endocarditis
European Journal of Internal Medicine, Vol. 64, pp. 63-71
2018
-
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients
Clinical Microbiology and Infection, Vol. 24, Núm. 5, pp. 546.e1-546.e8
-
Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial
Clinical Microbiology and Infection
-
Epidemiology and risk factors for Clostridium difficile infection in critically ill patients in Spain: The PROCRID study
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 4, pp. 218-221
-
Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis
Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562
2017
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672
-
MIC of amoxicillin/clavulanate according to CLSI and EUCAST: Discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 5, pp. 1478-1487
2016
-
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Mayo Clinic Proceedings, Vol. 91, Núm. 10, pp. 1362-1371
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: The Bacteraemia-MIC project
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 521-530
-
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 719-724